Vaccines and Immunization Research Expertise
Advancing Prevention Through Evidence
We deliver comprehensive vaccines and immunization research expertise by integrating immunological science, rigorous clinical development methodologies, and real-world evidence generation. Our work spans the full vaccine lifecycle - from clinical development and regulatory evaluation to post-licensure safety and effectiveness, across both routine and priority infectious diseases, including tuberculosis, cholera, and other endemic and emerging pathogens. We generate high-quality evidence that supports informed policy decisions, clinical practice, and population-level public health impact.
Broad Vaccine Coverage
- Experience across prophylactic and therapeutic vaccines, including pediatric, adult, and special-population immunization programs.
Diverse Study Designs
- Support for early- and late-phase clinical trials, post-marketing surveillance, observational studies, registries, and real-world evidence programs.
Safety, Immunogenicity and Effectiveness Endpoints
- Evaluation of adverse events, reactogenicity, immune response markers, durability of protection, breakthrough infections, and population-level effectiveness.
Real-World Evidence
- Use of healthcare records, immunization registries, surveillance systems, and longitudinal follow-up data to assess vaccine performance beyond controlled trial environments.
Advanced Epidemiology and Biostatistics
- Application of robust epidemiological frameworks to address confounding, bias, and population heterogeneity, enabling reliable assessment of benefit–risk profiles.
Public Health and Policy-Relevant Outputs
- Evidence generation aligned with national and international immunization guidelines to support regulatory submissions, programmatic decisions, and health system planning.
End-to-End Research Execution
- Comprehensive support across study design, regulatory and ethics submissions, site and community coordination, data management, statistical analysis, and scientific dissemination.
